Jiang, Zhichao
Xie, Yibin
Zhang, Wen
Du, Chunxia
Zhong, Yuxin
Zhu, Yuelu
Jiang, Liming
Dou, Lizhou
Shao, Kang
Sun, Yongkun
Xue, Qi
Tian, Yantao
Gao, Shugeng
Zhao, Dongbing
Zhou, Aiping http://orcid.org/0000-0003-1632-837X
Article History
Received: 3 November 2023
Accepted: 20 January 2024
First Online: 8 March 2024
Declarations
:
: The authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The protocol was approved by the Ethical Committee of the National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (15–077/1004). Clinical trial information: NCT02725424. Written informed consent was obtained from all individual participants included in the study. This study followed the CONSORT reporting guideline for randomized studies.